Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.

Tralene Williams, a state employee of 18 years, holds a Wegovy pen prior to administering a once weekly injection on Wednesday, Jan. 31, 2024, in Knightdale, N.C. Leaders of the State Health Plan ...

Some people who take Ozempic or Wegovy (semaglutide ... injection pens load different amounts of medicine with each click. A 1 mg pen and an 8 mg pen require different click charts, and using ...

If you've never used an injection pen before, that might seem intimidating. But learning a few key techniques-including ...

Semaglutide is also used in the diabetes treatment Ozempic. Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm ...

Our list of online Wegovy providers includes reputable brands with licensed healthcare providers who can support you on your weight loss journey. Dozens of online retailers are offering Wegovy ...

Wegovy Q3 sales total $2.5 bln Beat forecast but group sales weaker than expected Results soothe investor worries over slowing obesity drug demand Shares rose nearly 9%, but later reversed course ...

Novo Nordisk’s weight loss drug Wegovy helped people with a fatty liver disease called MASH experience improvements in liver scarring and achieve symptom resolution, results the company sees as ...

Westend61/Getty Images The use of GLP-1 medications such as semaglutide — more widely known under the brand names of Ozempic and Wegovy — have greatly increased over the last few years.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking this class of drugs ...

Novo Nordisk’s blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares 8.5% higher in early trade. Soaring popularity for its obesity drug has seen ...